Veterinary Infectious Disease Diagnostics Market is expected to reach a valuation of US$ 4.9 billion by 2033
The global Veterinary Infectious Disease Diagnostics Market is projected to have a high-paced CAGR of 10.1% during the forecast period. The current valuation of the veterinary infectious disease diagnostics market is US$ 1.9 billion in 2023. The value of the veterinary infectious disease diagnostics market is anticipated to reach a high of US$ 4.9 billion, by the year 2033.
The market for veterinary infectious
disease diagnostics is expected to expand over the coming years due to rising
numbers of veterinarians in developed economies and expanding disease control
and illness prevention initiatives.
Get Full Access @ https://www.futuremarketinsights.com/reports/veterinary-infectious-disease-diagnostics-market
The increased frequency of
infectious animal illnesses is predicted to further fuel the demand for
veterinary diagnostics. Additionally, improvements in diagnostics and an
increasing adoption of novel procedures in the majority of laboratories are
fueling market expansion. For instance, FORCE Technology established
AeroCollect A/S in August 2021 as a new business.
The AeroCollect technique provides a
picture of the illnesses in a herd using straightforward air samples. Animal
diagnostics have undergone a revolution owing to the Danish researchers at the
GTS institute FORCE Technology. Presently, the swine, poultry, and mink
industries employ AeroCollect technology. The worldwide COVID-19 pandemic has
had an effect on every industry.
No animal can spread this virus,
according to the OIE. A veterinary parameter was added to the K+ Potassium test
offered by EurolyserDiagnostica GmbH in November 2018. The popularity of
veterinary point-of-care devices is anticipated to rise throughout the
projected period due to their quick and affordable manner of diagnostics. The
change in veterinary point-of-care diagnostics has been facilitated by
developments in lateral flow technologies, such as microfluidics.
The prevalence of pet insurance in
North America has increased the likelihood that owners would subject their
animals to diagnostic testing. Similar to how more diagnostic tests stop
illnesses from spreading, the growth in zoonotic diseases is one of the main
reasons for doing so. According to a research document by the World Wildlife
Fund that was published in August 2020, zoonoses account for 60.3% of all newly
developing illnesses.
Over the past few years, there has been a steady rise in the adoption of pets. For instance, according to the American Pet Products Association, the number of cats, dogs, and horses adopted countrywide increased from 172.5 million in 2011–2012 to 191.5 million in 2017–2018. (APPA). Numerous European nations have supportive regulations for companion animals. A few notable examples include the Commission Laws of the French National Assembly from 2014, the Civil Code of the Czech Republic from 2012, the Animal Welfare Act of the United Kingdom from 2006, the Austrian Constitution from 2004, the German Constitution from 2002, and the Swiss Law from October 4, 2002.
However, the adoption of
point-of-care diagnostic devices among healthcare professionals is anticipated
to be constrained by several reasons, such as low sensitivity of the results
that might provide false positive or incorrectly negative results. The
potential for animal neglect and the shortage of qualified specialists to
analyze the gathered clinical data are constraints limiting the expansion of
the veterinary infectious disease diagnostics market size.
Key Takeaways:
- During the anticipated period, the United States is
anticipated to lead the global veterinary infectious disease diagnostics
market. In the United States, veterinary diagnostics are meant to assist
veterinarians utilize medicines wisely, while also developing methods to
combat animal diseases and zoonoses.
- Japan is predicted to dominate the Asia Pacific
veterinary infectious diseases diagnostics market throughout the forecast
period. In order to improve animal health, major firms in Japan are
offering diagnostic services using modern technology to identify novel
ailments, particularly exotic diseases. In response to requests from the
national and local governments of Japan, this is carried out.
- Owing to its increasing sales and the rising occurrence
of animal illnesses, the "immunodiagnostics" technology type is
expected to hold the greatest revenue through the forecast period.
- As pet popularity increases and pet insurance becomes
more widely used, the "companion animal” animal type, and is the most
creative segment for key companies, accounting for a sizable portion.
Competitive Landscape:
The global veterinary infectious
disease diagnostics market share is fragmented as a result of both domestic and
international competitors. Several companies command substantial market shares
in their respective specialty areas. Large corporations generally give natural
events like product approvals and the rise in pet adoption around the world a
significant amount of importance. The market for veterinary infectious disease
diagnostics is predicted to expand quickly as a result of these factors.
Key Players:
- Zoetis Inc.
- Thermo Fisher Scientific
- Virbac
- Biomerieux SA
- Heska Corporation
- IDvet
- NEOGEN Corporation
- QIAGEN N.V.
- Randox Laboratories Ltd.
Recent Developments:
ü In September 2018, Equine
Progesterone, a test for determining the progesterone level in horses, was
released, according to Eurolyser Diagnostica GmbH.
ü In January 2019, the
Catalyst One and Catalyst Dx analyzers, an in-house testing technique for the
measurement of progesterone levels in dogs, were launched by IDEXX
Laboratories, Inc.
Key Segments Profiled in the
Veterinary Infectious Disease DiagnosticsMarket Survey
By Technology:
- Immunodiagnostics
- Molecular Diagnostic
- Others
By Animal Type:
- Companion Animal
- Food-producing Animals
By End User:
- Reference Laboratories
- Veterinary Hospitals & Clinics
- Point-of-Care
- Research Institutes & Universities
Comments
Post a Comment